Joinn Laboratories(China)Co.,Ltd.
603127
Clasificación en acciones
#3812
Joinn Laboratories (China) Co., Ltd. delivers a comprehensive suite of... Joinn Laboratories (China) Co., Ltd. delivers a comprehensive suite of preclinical and non-clinical services to clients across the United States, China, and other international regions. The company's business is organized into three core operational areas. Its Non-Clinical Studies Services segment focuses on drug safety assessment, drug metabolism and pharmacokinetics analysis, and pharmacology and efficacy investigations. The Clinical Trial and Related Services division offers contract research organization (CRO) support for clinical trials, co-manages Phase I clinical research units, and provides bioanalytical services. Furthermore, the Sales of Research Models segment is involved in the design, production, breeding, and distribution of various research models, including non-human primates and rodents. Beyond these offerings, Joinn Laboratories also provides investment management and cell-based assay (CBA) services. Founded in 1995, the company is headquartered in Beijing, China.
Precio por acción
$6.82
Capitalización bursátil
$4.30B
Cambio (1 día)
-6.30%
Cambio (1 año)
48.79%
País
CN
Comercio Joinn Laboratories(China)Co.,Ltd. (603127)
Categoría
Healthcare
Ingresos de Joinn Laboratories(China)Co.,Ltd. (603127)
Ingresos en Oct 2026 TTM: 0
Según los últimos informes financieros de Joinn Laboratories(China)Co.,Ltd., los ingresos actuales de la empresa (TTM) son 0. En 2026, la empresa obtuvo unos ingresos de 0 igual a los ingresos del año 2026, que fueron de 0. Los ingresos representan la cantidad total que una empresa genera por la venta de bienes o servicios. A diferencia de las ganancias, no se restan los gastos.
Historial de ingresos de Joinn Laboratories(China)Co.,Ltd. desde 2012 hasta 2026
Ingresos al final de cada año
| Año | Ingresos | Cambiar |
|---|---|---|
| 2025 | $236.93M | -14.32% |
| 2024 | $276.52M | -17.64% |
| 2023 | $335.73M | 2.11% |
| 2022 | $328.79M | 37.79% |
| 2021 | $238.63M | 44.89% |
| 2020 | $164.70M | 79.37% |
| 2019 | $91.82M | 54.50% |
| 2018 | $59.43M | 28.34% |
| 2017 | $46.31M | 32.96% |
| 2016 | $34.83M | 9.47% |
| 2015 | $31.82M | 6.63% |
| 2014 | $29.84M | 25.84% |
| 2013 | $23.71M | 51.82% |
| 2012 | $15.62M | 0.00% |
Ingresos de empresas similares o competidoras
| Empresa | Ingresos | Diferencia de ingresos | País |
|---|---|---|---|
| $47.35B | - |
US
|
|
| $25.61B | - |
US
|
|
| $2.71B | - |
US
|
|
| - | - |
CN
|
|
| $7.37B | - |
US
|
